Hyewon Nina Koo is passionate about examining the effects of medications/treatments, estimating the risks of disease occurrence and providing personalized patient care in the pharmaceutical and healthcare industry.
AI and Self-Service Access to Real-World Data in Clinical Research
Why AI’s transformative potential depends on courageous leaders
Leadership, Method, and Accountability in an Accelerating Era
A practical framework for aligning AI with mission, operational priorities, governance, and measurable impact
Time to ground, connect and a strong cup of coffee
Time to ground, conntect and a strong cup of coffee
an interactive session for both practitioners and academics (10:00-12:30)
Insightful perspectives relevant for many industries
Format: Curated dialogue + audience interaction
What would change if the success of artificially-intelligent driven research were measured by the risks it prevents, not only the breakthroughs it produces?
Opening Dialogue
A forward-looking pre-workshop dialogue
Curated dialogue with audience interaction
Cross-Functional Intelligence and Intent Engineering
The Conditional Impact of AI on Innovation Performance
AI can scale safety insights—but only high-quality data, interoperability, and expert judgment make them trustworthy.
more panelists to be announced)
Rethinking AI, Expertise, and Innovation in Research-Intensive Organizations
An example from the Health Industry - relevant for everyone
Warm welcome to the CLAIR Conference but Mats and Luciano
A short scientific introduction